CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-06-29 | KNOTT DAVID M 10% owner | Sale | −55,500 | $2.52 | $140K | 1,140,000 |
| 2009-06-29 | KNOTT DAVID M 10% owner | Sale | −53,800 | $2.52 | $136K | 1,784,153 |
| 2009-06-29 | KNOTT DAVID M 10% owner | Sale | −300 | $2.52 | $756 | 70,100 |
| 2009-05-29 | FAHIM RAAFAT E F President, CEO and CFO | Other acquisition | +5,404.28 | $2.41 | $13K | 278,414.66 |
| 2009-05-22 | SUDOVAR STEPHEN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-05-22 | LYNCH TIMOTHY P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-05-22 | JENCKES LINDA Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-05-22 | HARVEY RICHARD A JR Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-05-22 | DAVIS PETER B Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-05-22 | COX GEOFFREY F Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2009-05-22 | CASTALDI DAVID L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-05-22 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2009-04-01 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Grant or award | +18,000 | 45,692.82 | ||
| 2009-04-01 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2009-04-01 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Grant or award | +30,000 | 101,240 | ||
| 2009-04-01 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2009-04-01 | FAHIM RAAFAT E F President, CEO and CFO | Grant or award | +45,000 | 270,063.53 | ||
| 2009-04-01 | FAHIM RAAFAT E F President, CEO and CFO | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2009-01-12 | KNOTT DAVID M 10% owner | Purchase | +58,500 | $3.84 | $225K | 139,800 |
| 2008-05-07 | SUDOVAR STEPHEN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 35 of 42 · 830 trades